SystemsX.ch: 9th call results
With a total of 69 submissions, the 9th call has generated more proposals than any other SystemsX.ch call to date. 28 proposals for Transition Postdoc Fellowships (TPdFs) and 41 for Interdisciplinary PhD Projects (IPhDs) have been submitted. Of these proposals, the SystemsX.ch Executive Board (SEB) and the Swiss National Science Foundation (SNSF) have approved 7 TPdF and 17 IPhD projects. more»
Long antibiotic treatments: slowly growing bacteria to blame
Whether pneumonia or sepsis – infectious diseases are becoming increasingly difficult to treat. One reason for this is the growing antibiotic resistance. But even non-resistant bacteria can survive antibiotics for some time, and that’s why treatments need to be continued for several days or weeks. Scientists at the Biozentrum of the University of Basel showed that bacteria with vastly different antibiotic sensitivity coexist within the same tissue. In the scientific journal Cell they report that, in particular, slowly growing pathogens hamper treatment.
This research was supported by SystemsX.ch RTD Project BattleX.
Read the press release published by the University of Basel »
SystemsX.ch: 9th Call Submissions
The aim of the 9th SystemsX.ch Call for Proposals was to support young scientists in becoming truly interdisciplinary researchers within the diverse field of systems biology. In response to the 9th call, 69 proposals for Transition Postdoc Fellowships (TPdFs) and Interdisciplinary PhD projects (IPhDs) have been submitted. more »
Cellular traffic control system mapped for the first time
The transport routes of nutrients and messenger cargos can be compared to the traffic system of a city: A worldwide unique quantitative study of cell biologists of the University of Zurich shows that cells regulate the main routes, side routes and intersections by an intricate traffic control system, which guides the spatial and temporal distribution of substances within the cell.
This research was supported by SystemsX.ch RTD Projects PhosphoNetX and LipidX. Read the News Release published by the UZH Mediadesk»